Status:

COMPLETED

Red Yeast Rice and Phytosterols In Statin Intolerance

Lead Sponsor:

Chestnut Hill Health System

Conditions:

Hyperlipidemia

Eligibility:

All Genders

21+ years

Phase:

PHASE2

PHASE3

Brief Summary

Red yeast rice may be useful to lower cholesterol, especially in a population of patients who cannot tolerate traditional therapy with statins. The addition of an over-the-counter phytosterol to red ...

Detailed Description

Although recent studies have shown that red yeast rice is an effective therapy in the treatment of hyperlipidemia, additional supplements may be required to lower cholesterol to levels that have been ...

Eligibility Criteria

Inclusion

  • Men and women age \> 21
  • LDL \> 100 and physician suggestion to take statin
  • Subject complains of muscle weakness or aching which he/she or his/her physician feels may be attributable to statin therapy
  • Having stopped a statin drug for personal reasons and not willing to restart this medication
  • Refusal to take a statin as prescribed by personal physician
  • CPK \< 400
  • Not taking any cholesterol lowering medication, red yeast rice extract or a phytosterol product for at least 1 month prior to initiation of trial
  • Ability to exercise without physical restrictions
  • Ability to attend 12 week consecutive Change of Heart lifestyle education sessions
  • Liver function studies normal at baseline
  • Subject willing to remain off the dietary supplement CoQ10 for duration of trial
  • TSH must be normal

Exclusion

  • A history of muscle damage (CPK \> 400 IU) on statin therapy
  • Any active cardiac problem including chest pain, angina, shortness of breath with minimal activity, or unstable angina/acute coronary syndrome within one year
  • Known intolerance to one of the study drugs
  • Physical limitation preventing aerobic exercise program, such as severe arthritis, peripheral vascular disease, congestive heart failure, or symptom limiting pulmonary disease
  • Uncontrolled hypertension (defined as SBP \> 180 mmHg or DBP \> 100 mmHg
  • Heart attack, bypass surgery, or angioplasty/stent within 1 year of study
  • Triglyceride level more than 400 mg/dl
  • Underlying musculoskeletal disorder preventing muscle testing
  • Taking other medicines including: cyclosporine, erythromycin or other macrolide antibiotics; fluconazole; niacin; fibrates; or \> 16 oz. of grapefruit juice daily

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00897975

Start Date

July 1 2009

End Date

July 1 2011

Last Update

July 18 2011

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Abington Memorial Hospital

Abington, Pennsylvania, United States

2

Chestnut Hill Hospital

Philadelphia, Pennsylvania, United States, 19118